A 67-year-old male with recently diagnosed amyloidosis presented to our hospital with acute bilateral lower extremity deep vein thrombosis. He was diagnosed with amyloid light chain amyloidosis 3 months prior to presentation and had been treated with one cycle of cyclophosphamide--bortezomib--dexamethasone. On physical examination, he was noted to have mildly enlarged tongue with lateral scalloping ([Fig. 1](#F0001){ref-type="fig"}). He did not have any difficulty with speech or eating.
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Macroglossia is an abnormal enlargement of the tongue in comparison to the mouth and jaws. It commonly leads to a scalloped appearance on the lateral margins of the tongue caused by the enlarged tongue pushing against the teeth ([@CIT0001]). Macroglossia and tongue scalloping is a non-specific sign which may be associated with a variety of infiltrative or inflammatory conditions like Down syndrome, hypothyroidism, tuberculosis, sarcoidosis, amyloidosis, multiple myeloma, neurofibromatosis, infection (e.g., syphilis), and angioedema ([@CIT0001]). However, it is important to remember that tongue scalloping without macroglossia can be seen with obstructive sleep apnea and is a useful clinical predictor of sleep pathology ([@CIT0002]).

Macroglossia with scalloping is seen in about 15% of cases of amyloid light chain amyloidosis ([@CIT0003]). It may be a part of generalized amyloidosis or a localized oral amyloid deposition ([@CIT0004]). Macroglossia usually resolves with the treatment of underlying amyloidosis, with rare cases with significant obstruction needing surgery ([@CIT0004]).

In conclusion, it is important to consider macroglossia as a sign of some underlying disorder like amyloidosis. Focused diagnostic testing, including possible biopsy, should be considered ([@CIT0005]).
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